GILD
Gilead Sciences, Inc.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$151.00
−0.15%Forward multiples
Based on analyst estimates
- P/E forward
- 16.69x
- P/E 2026E
- —
- P/E 2027E
- 15.28x
- P/E 2028E
- 14.17x
- P/S forward
- 5.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 15.83x
- Price / sales
- 6.15x
- Price / cash flow
- 13.82x
Enterprise value
- Enterprise value
- $210.2B
- EV / sales
- 6.90x
- EV / EBITDA
- 330.52x
- EV / EBIT
- -140.80x
- Market cap
- $187.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026